Mainz Biomed公司和Thermo Fisher公司合作伙伴开发新的直肠癌筛查测试。 Companies Mainz Biomed and Thermo Fisher partner to develop a new colorectal cancer screening test.

Mainz Biomed和热热渔业科学公司已合作开发新的直肠癌筛查测试并将其商业化。 Mainz Biomed and Thermo Fisher Scientific have partnered to develop and commercialize a new colorectal cancer screening test. Mainz Biomed的以MRNA为基础的试验在临床试验、检测癌症和先发性损伤方面取得成功。 Mainz Biomed's mRNA-based test, which has shown success in clinical trials, detects cancer and precancerous lesions. 热热渔夫的先进技术将有助于为筛选产品开发专有性化验,目的是改进全球早期癌症检测。 Thermo Fisher's advanced technologies will aid in developing proprietary assays for the screening product, aiming to improve early cancer detection globally.